Alessio Gili

Professore Associato

Link Campus University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alessio Gili is an Associate Professor at Link Campus University in Italy. His research areas include health profiles of inmates, cancer epidemiology, and the application of machine learning in predicting clinical outcomes. He has contributed to significant studies on lung cancer detection, renal cell carcinoma treatment, and the long-term effects of the COVID-19 pandemic on substance use disorders.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Giovanni Maifredi

ITALY

View details

Paolo Contiero

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Massimo Lancia

PROFESSORE ASSOCIATO

Università degli Studi di Napoli Federico II

ITALY

View details

Gianluca Costa

Saint Camillus International University of Health Sciences

ITALY

View details

Andrea Tittarelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Antonio Giampiero Russo

Adjunct Professor

University of Milan

ITALY

View details

Cristiana Gambelunghe

University of Perugia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessio Gili

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Health Profiles of Inmates: A Cross-Sectional Study of Prevalent Diseases in a Central Italian Prison

Trends in cancer incidence and mortality in Italy, 2013–2017

A Comparison of Machine Learning-Based Models and a Simple Clinical Bedside Tool to Predict Morbidity and Mortality After Gastrointestinal Cancer Surgery in the Elderly

Fast-Track Diagnostic Pathway for Lung Cancer Detection: Single-Center Experience

Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study

Long-Term Impacts of the COVID-19 Pandemic on Drug/Alcohol Use Prevalence in a Population with Substance Use Disorders

Impact of rehabilitation treatment during the acute phase of SARS-CoV-2 infection.

The descriptive epidemiology of melanoma in Italy has changed - for the better.

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.

Correction: Value of hospital datasets of COVID-19 patients across different pandemic periods: challenges and opportunities.

Socio-Economic Factors Associated with Ethnic Disparities in SARS-CoV-2 Infection and Hospitalization

Patterns of Prescription Medicine, Illicit Drugs, and Alcohol Misuse among High-Risk Population: A Factor Analysis to Delineate Profiles of Polydrug Users

Role of Nucleocapsid Protein Antigen Detection for Safe End of Isolation of SARS-CoV-2 Infected Patients with Long Persistence of Viral RNA in Respiratory Samples

Accuracy and Impact on Patient Management of New Tools for Diagnosis of Sepsis: Experience with the T2 Magnetic Resonance Bacteria Panel

Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy

Collaborators (7)

Giovanni Maifredi

Paolo Contiero

Massimo Lancia

Gianluca Costa

Andrea Tittarelli

Antonio Giampiero Russo

Cristiana Gambelunghe

Make your next move.